Fig. 2From: Highlight selection of radiochemistry and radiopharmacy developments by editorial board(adapted from Borgna et al. 2022)AR42J tumor cell viability (MTT assay) and Kaplan–Meier plot (2 × 10 MBq; 0.2 nmol) for 161Tb- and 177Lu-labeled SSTR agonists (DOTATOC) and antagonists (DOTA-LM3) in AR42J tumor-bearing mice.Back to article page